{"id":"NCT04133311","sponsor":"Santen SAS","briefTitle":"A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension","officialTitle":"A Phase III, Multinational, Multicenter, Investigator-Masked, Randomized, Active Controlled Trial, Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension Over a 3-Month Period, Followed by a 12-Month Follow-Up With Open-Label DE-130A Treatment.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-10","primaryCompletion":"2022-02-03","completion":"2022-10-26","firstPosted":"2019-10-21","resultsPosted":"2024-05-28","lastUpdate":"2024-05-28"},"enrollment":386,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Open-Angle Glaucoma or Ocular Hypertension","Ocular Surface Disease"],"interventions":[{"type":"DRUG","name":"DE-130A","otherNames":["Catiolanze®"]},{"type":"DRUG","name":"Xalatan®","otherNames":[]},{"type":"DRUG","name":"DE-130A/DE-130A","otherNames":["Catiolanze®"]},{"type":"DRUG","name":"Xalatan®/DE-130A","otherNames":["Catiolanze®"]}],"arms":[{"label":"DE-130A","type":"EXPERIMENTAL"},{"label":"Xalatan®","type":"ACTIVE_COMPARATOR"},{"label":"DE-130A/DE-130A","type":"OTHER"},{"label":"Xalatan®/DE-130A","type":"OTHER"}],"summary":"A Phase III, Multinational, Multicenter, Investigator-Masked, Randomized, Active-Controlled Trial, comparing the efficacy and safety of DE-130A with Xalatan® in Patients with Open-Angle Glaucoma or Ocular Hypertension over a 3-Month period, followed by a 12-Month Follow-Up with Open-Label DE-130A Treatment.","primaryOutcome":{"measure":"Intraocular Pressure (IOP) Change (mmHg) at Week 12","timeFrame":"Week 12 (09:00) peak timepoint","effectByArm":[{"arm":"DE-130A","deltaMin":-8.8,"sd":0.25},{"arm":"Xalatan®","deltaMin":-8.2,"sd":0.26}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["France"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":193},"commonTop":["Ocular hyperaemia","Abnormal sensation in eye","Conjunctival hyperaemia","COVID-19","Swelling of eyelid"]}}